FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valera, A.
Right arrow Articles by Bosch, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valera, A.
Right arrow Articles by Bosch, F.

The FASEB Journal, Vol 9, 1067-1078, Copyright © 1995 by The Federation of American Societies for Experimental Biology


RESEARCH COMMUNICATIONS

Evidence from transgenic mice that myc regulates hepatic glycolysis

A Valera, A Pujol, X Gregori, E Riu, J Visa and F Bosch
Department of Biochemistry and Molecular Biology, School of Veterinary Medicine, Autonomous University of Barcelona, Bellaterra, Spain.

The product of the c-myc proto-oncogene (c-Myc) is involved in the control of cell proliferation, differentiation, and apoptosis. It acts as a transcription factor that recognizes the CACGTG motif. This sequence has also been found in the glucose-responsive elements of genes involved in the control of liver glycolysis and lipogenesis. To determine whether c-Myc can regulate hepatic carbohydrate metabolism in vivo, transgenic mice that overexpress c-myc under control of the P- enolpyruvate carboxykinase (PEPCK) gene promoter have been generated. These mice showed a threefold increase in c-Myc protein in liver nuclei. Hepatocytes from transgenic mice were normal and did not acquire the fetal phenotype. However, transgenic mice showed higher levels (threefold) of L-type pyruvate kinase mRNA and enzyme activity than control mice. The increase in pyruvate kinase activity led to a three- to fivefold increase in liver lactate content and a fivefold induction of lactate production by hepatocytes in primary culture. The expression of the 6-phosphofructo-2-kinase gene was also increased in the liver of these transgenic mice. The induction of hepatic glycolysis was related with an increase in the expression (about fourfold) and activity (about threefold) of liver glucokinase, whereas no change was noted in hexokinase-I. This change in glucokinase activity led to an increase in both glucose 6-phosphate and glycogen contents in the liver of transgenic mice. The expression of the liver-specific glucose transporter GLUT2 was also increased in transgenic mice, whereas no change was noted in the mRNA concentration of GLUT1. Furthermore, the changes of liver glucose metabolism led to a marked reduction of blood glucose (25%) and insulin (40%) concentrations in starvation, whereas the fall in both was only 10% in fed mice. Thus, liver glucose metabolism could determine the blood glucose and insulin set points in the transgenic mice. All these results indicated that the increase in c- Myc protein was able to induce liver glucose utilization and accumulation, and suggested that c-Myc transcription factor is involved in the control in vivo of liver carbohydrate metabolism.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
J. J. Collier and D. K. Scott
Sweet Changes: Glucose Homeostasis Can Be Altered by Manipulating Genes Controlling Hepatic Glucose Metabolism
Mol. Endocrinol., May 1, 2004; 18(5): 1051 - 1063.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. J. Collier, T.-T. T. Doan, M. C. Daniels, J. R. Schurr, J. K. Kolls, and D. K. Scott
c-Myc Is Required for the Glucose-mediated Induction of Metabolic Enzyme Genes
J. Biol. Chem., February 14, 2003; 278(8): 6588 - 6595.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Riu, A. Mas, T. Ferre, A. Pujol, L. Gros, P. Otaegui, L. Montoliu, and F. Bosch
Counteraction of Type 1 Diabetic Alterations by Engineering Skeletal Muscle to Produce Insulin: Insights From Transgenic Mice
Diabetes, March 1, 2002; 51(3): 704 - 711.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Subramanian and D. M. Miller
Structural Analysis of alpha -Enolase. MAPPING THE FUNCTIONAL DOMAINS INVOLVED IN DOWN-REGULATION OF THE c-myc PROTOONCOGENE
J. Biol. Chem., February 25, 2000; 275(8): 5958 - 5965.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. V. Dang
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Mol. Cell. Biol., January 1, 1999; 19(1): 1 - 11.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Shim, C. Dolde, B. C. Lewis, C.-S. Wu, G. Dang, R. A. Jungmann, R. Dalla-Favera, and C. V. Dang
c-Myc transactivation of LDH-A: Implications for tumor metabolism and growth
PNAS, June 24, 1997; 94(13): 6658 - 6663.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Roche, F. Assimacopoulos-Jeannet, L. A. Witters, B. Perruchoud, G. Yaney, B. Corkey, M. Asfari, and M. Prentki
Induction by Glucose of Genes Coding for Glycolytic Enzymes in a Pancreatic beta -Cell Line (INS-1)
J. Biol. Chem., January 31, 1997; 272(5): 3091 - 3098.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. C. Osthus, H. Shim, S. Kim, Q. Li, R. Reddy, M. Mukherjee, Y. Xu, D. Wonsey, L. A. Lee, and C. V. Dang
Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc
J. Biol. Chem., July 14, 2000; 275(29): 21797 - 21800.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by The Federation of American Societies for Experimental Biology.